'What Ifs' for America's Research Consortia

Perhaps at no time since the Second World War has there been such an emphasis on the rapid transfer of research findings to development. The 1980s have seen the birth of dozens of research consortia designed to quicken the pace of technological development in the United States. Coming from a wide array of businesses and varied academic institutions, these R&D consortia are seen by many as the answer to the United States' regaining the lead it has lost in technological competitiveness. In The New

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

What are the prospects? Marc Tucker [director of the Carnegie Forum in Washington, D.C.] views the advent of research and development consortia with a cool dose of practicality. "If you were to look at these consortia as the principal instrument for adjusting to the problems that we face economically, I would have to say: 'Ridiculous.' They don't begin to get at the larger problems that we face. On their own terms, though, they are incredibly valuable contributions." His observation opens the question of whether the scale of the response represented by industry-university consortia is commensurate with the sense of threat to survival felt by American industry.

The first answer, then, to the "what if' question is that more consortia, properly capitalized and led, could well serve to accelerate the move toward a national technology agenda. This raises immediate questions of national policy. Should the federal government—following the recent lead of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Dan Dimancescu

    This person does not yet have a bio.

Published In

Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development